Important considerations regarding the widespread use of doxycycline chemoprophylaxis against sexually transmitted infections
Rates of sexually transmitted infections (STIs) continue to rise across the world and
interventions are essential to reduce their incidence. Past and recent studies have indicated …
interventions are essential to reduce their incidence. Past and recent studies have indicated …
[HTML][HTML] Seventy years of Chlamydia vaccine research–limitations of the past and directions for the future
S Phillips, BL Quigley, P Timms - Frontiers in microbiology, 2019 - frontiersin.org
Chlamydia is a major bacterial pathogen that infects humans, as well as a wide range of
animals, including marsupials, birds, cats, pigs, cattle, and sheep. Antibiotics are the only …
animals, including marsupials, birds, cats, pigs, cattle, and sheep. Antibiotics are the only …
Human and pathogen factors associated with Chlamydia trachomatis-related infertility in women
Chlamydia trachomatis is the most common bacterial sexually transmitted pathogen
worldwide. Infection can result in serious reproductive pathologies, including pelvic …
worldwide. Infection can result in serious reproductive pathologies, including pelvic …
Azithromycin versus doxycycline for the treatment of genital chlamydia infection: a meta-analysis of randomized controlled trials
Background. There has been recent debate questioning the efficacy of azithromycin for the
treatment of urogenital chlamydia infection. We conducted a meta-analysis to compare the …
treatment of urogenital chlamydia infection. We conducted a meta-analysis to compare the …
Mechanism of action, resistance, synergism, and clinical implications of azithromycin
M Heidary, A Ebrahimi Samangani… - Journal of clinical …, 2022 - Wiley Online Library
Background Azithromycin (AZM), sold under the name Zithromax, is classified as a
macrolide. It has many benefits due to its immunomodulatory, anti‐inflammatory, and …
macrolide. It has many benefits due to its immunomodulatory, anti‐inflammatory, and …
Chlamydia trachomatis and Genital Mycoplasmas: Pathogens with an Impact on Human Reproductive Health
The most prevalent, curable sexually important diseases are those caused by Chlamydia
trachomatis (C. trachomatis) and genital mycoplasmas. An important characteristic of these …
trachomatis (C. trachomatis) and genital mycoplasmas. An important characteristic of these …
Azithromycin antimicrobial resistance and genital Chlamydia trachomatis infection: duration of therapy may be the key to improving efficacy
PJ Horner - Sexually transmitted infections, 2012 - sti.bmj.com
A test of cure following treatment for uncomplicated cervical or urethral Chlamydia
trachomatis infection with either single dose azithromycin (1 g) or doxycyline (100mg twice …
trachomatis infection with either single dose azithromycin (1 g) or doxycyline (100mg twice …
Doxycycline in the management of sexually transmitted infections
H Peyriere, A Makinson, H Marchandin… - Journal of …, 2018 - academic.oup.com
Doxycycline is a second-generation tetracycline, available worldwide for half a century. It is
an inexpensive broad-spectrum antimicrobial agent largely used in the management of …
an inexpensive broad-spectrum antimicrobial agent largely used in the management of …
Treatment challenges for urogenital and anorectal Chlamydia trachomatis
While true antimicrobial resistance to Chlamydia trachomatis is a rare occurrence, repeat
chlamydia infections continue to be reported following treatment with a single 1 g dose of …
chlamydia infections continue to be reported following treatment with a single 1 g dose of …
Doxycycline Post-exposure Prophylaxis for bacterial sexually transmitted infections: The current landscape and future directions
LT Allan-Blitz, KH Mayer - Current HIV/AIDS Reports, 2025 - Springer
Doxycycline Post-Exposure Prophylaxis for Bacterial Sexually Transmitted Infections: The
Current Landscape and Future Directions | Current HIV/AIDS Reports Skip to main content …
Current Landscape and Future Directions | Current HIV/AIDS Reports Skip to main content …